Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 509 of 5804
-
Laser breakthrough could speed up retinal detachment recovery
Disease control Recruiting nowThis study is a first-in-human clinical trial testing a new treatment for rhegmatogenous retinal detachments. The new treatment called retinal thermofusion uses a special laser device called iSeelr™ during surgery. The benefit of the device is that it repairs retinal tears withou…
Phase: NA • Sponsor: Photofuse Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for rare vascular malformations: targeted drugs enter trial
Disease control Recruiting nowRecent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specific to these pathways have been developed and shown to be effective in treating cancer. This study will describe the effec…
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a DIY swab replace the speculum for cervical cancer screening?
Diagnosis OngoingThis clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections …
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Could a common supplement ease gulf war illness symptoms?
Disease control Recruiting nowThe purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Phase: PHASE3 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental cocktail aims to tackle tough blood cancers
Disease control Recruiting nowThe purpose of this study is to learn more about LP-118 (an experimental drug) and its side effects and decide on acceptable doses. The purpose of this study is to determine if LP-118 can be given safely with another medicine called ponatinib, that is FDA-approved for the treatme…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a targeted drug boost chemo success in leukemia?
Disease control Recruiting nowThis phase II MyeloMATCH treatment trial compares cytarabine with daunorubicin versus cytarabine with daunorubicin and venetoclax versus venetoclax with azacitidine for the treatment of younger patients with intermediate risk acute myeloid leukemia (AML). Cytarabine is a drug tha…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a quick online therapy stop PTSD before it starts?
Prevention Recruiting nowA significant proportion of people who are exposed to traumatic events suffer from post-traumatic sequelae, such as post-traumatic stress disorder (PTSD). Indicated preventive interventions soon after trauma could be appropriate. Yet, there is limited evidence for the efficacy of…
Phase: NA • Sponsor: Norwegian Center for Violence and Traumatic Stress Studies • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy aims to cut relapse in rare lymphoma
Disease control ENROLLING_BY_INVITATIONIn the past 10 years, there have been many effective explorations on the treatment of NK/TCL at home and abroad, which has innovated the treatment mode. Since ENKTCL-NT cells are sensitive to radiotherapy, radiotherapy is considered to be the most reliable treatment for ENKTCL-NT…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug targets tough cancers with KRAS G12D mutation
Disease control Recruiting nowThe main purpose of this study is to assess safety \& tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor types. The study is expected to last approximately 5 …
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI could prevent sudden cardiac death in young athletes
Diagnosis Recruiting nowAnomalous aortic origin of the coronary arteries (AAOCA) is a rare congenital disease and one of the leading causes of sudden cardiac deaths (SCD) in young athletes but also has a lethal presentation in adult age with myocardial infarction, even if not related to obstructive coro…
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Campus sweep: rapid chagas tests could uncover thousands of hidden cases
Diagnosis CompletedThe goal of this observational study is to improve access to diagnosis and treatment for chronic Trypanosoma cruzi infection among university students of all ages and genders at the National University of Salta (UNSa), Argentina. The main questions it aims to answer are: * What …
Sponsor: Mundo Sano Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Ketamine infusions could help curb meth addiction, new trial hopes
Disease control Recruiting nowThis study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week randomized, double-blind, controlled trial comparing intravenous (IV) ketamine agains…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Brain implant trial targets severe depression
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill could tame debilitating eye inflammation, major trial underway
Disease control OngoingThe purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Phase: PHASE3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Male birth control pill enters human testing
Disease control Recruiting nowThis is a Phase 1b/2a open-label, dose escalation 3 part-study, 28-day, 90-day or 180 day repeat dose study of YCT-529 in healthy males who have decided to have a vasectomy and are waiting for the procedure and for men who have decided not to father children in the future. The st…
Phase: PHASE1, PHASE2 • Sponsor: YourChoice Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo shows promise for Hard-to-Treat uterine cancer
Disease control OngoingThis is a 2 stage multi-center study designed to evaluate the efficacy of the combination of alpelisib and fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate (ORR). Treatment will continue until eithe…
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain pacemaker trial aims to stop Self-Harm in kids with autism
Disease control Recruiting nowDeep Brain Stimulation for the Treatment of Severe Refractory Self-Injurious Behaviour in Children with Autism Spectrum Disorder: A Randomized Trial To evaluate the effectiveness of deep brain stimulation (DBS) of the nucleus accumbens for the treatment of severe refractory, rep…
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Promising new combo aims to tame rare lymphoma with less radiation
Disease control OngoingInvestigate the efficacy and safety of Orelabrutinib followed by response-adapted ultra-low dose 4Gy radiation in the treatment of local-stage MALT lymphoma
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo therapy aims to slow advanced breast cancer
Disease control Recruiting nowPhase II clinical trial of PD-L1 in combination with vinorelbine + cyclophosphamide + capecitabine (VEX) metronomic chemotherapy with or without radiotherapy for advanced triple-negative breast cancer.
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Hope for ME/CFS and long COVID: new drug combo trial launches
Disease control Recruiting nowThe LIFT will be conducted at Brigham and Women's Hospital (BWH) of Harvard Medical School, focusing on the effect of Pyridostigmine (Mestinon) and Low-Dose Naltrexone (LDN) in subjects aged 18-70 meeting the Canadian consensus criteria (CCC) for Myalgic Encephalomyelitis/Chronic…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC